WHO guidelines conditionally endorse long-term GLP-1 therapy for obesity, emphasizing lifestyle modifications and addressing affordability and access challenges. GLP-1 therapies are included in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results